Feedback / Questions
crinecerfont (NBI-74788) - Neurocrine
Crinecerfont: "CAHtalystTM adult and pediatric study common endpoints"; Congenital adrenal hyperplasia
(Neurocrine Biosciences)
-
Nov 19, 2023 -
Q3 2023 Results
P3 data
•
Congenital Adrenal Hyperplasia
https://www.neurocrine.com//assets/2023/10/Final-NBIX-Q3-2023-Earnings-Presentation_10.31.23.pdf
Nov 19, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious